You are here

Article Text

Article menu
Download PDFPDF
Neurological picture
Late progression of neurological symptoms and MRI T2 hyperintensities in Parry-Romberg syndrome

https://doi.org/10.1136/jnnp-2016-313091

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors PD was involved in the drafting and revising the manuscript, conception of the study, analysis and interpretation of data, final approval. GH was involved in revising the manuscript, acquisition of data, analysis and interpretation of data, final approval. EB was involved in revising the manuscript, acquisition of data, analysis and interpretation of data, final approval. MO was involved in revising the manuscript, conception of the study, analysis and interpretation of data, final approval. PD takes responsibility for the integrity of the data and the accuracy of the data analysis.

    • Competing interests EB has received honoraria for lectures, from Biogen and Bayer Vital. MO has received scientific support, travel support and/or honoraria, from Biogen Idec, Novartis, Sanofi-Aventis, Genzyme, Pfizer, Teva and Heel, as well as receiving research grants from Allergan, Electrocore, Heel and the German Ministry for Education and Research (BMBF).

    • Patient consent Obtained.

    • Ethics approval Ethics committee of Asklepios clinics.

    • Provenance and peer review Not commissioned; externally peer reviewed.